Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the β-galactosidase and human factor IX genes to early gestation fetal sheep In Utero

Human Gene Therapy

Volumn 14, Issue 4, 2003, Pages 353-364

  David, Anna ^a   Cook, Terry ^b   Waddington, Simon ^b   Peebles, Donald ^a   Nivsarkar, Megha ^b   Knapton, Holly ^b   Miah, Maznu ^a   Dahse, Thomas ^b,d   Noakes, David ^c   Schneider, Holm ^d   Rodec, Charles ^a   Coutelle, Charles ^b   Themis, Mike ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 9; GENOMIC DNA; VIRUS VECTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; FETAL GENE THERAPY; FETUS; GENE THERAPY; GENETIC DISORDER; GESTATIONAL AGE; HUMAN; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SHEEP; SURVIVAL RATE; TRANSGENE; ULTRASOUND; UMBILICAL CORD; UMBILICAL VEIN; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ADMINISTRATION, CUTANEOUS; AMNION; ANIMALS; ANTIBODIES; BETA-GALACTOSIDASE; FACTOR IX; FEMALE; FETUS; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GESTATIONAL AGE; HUMANS; IMMUNE TOLERANCE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; LIVER; PREGNANCY; SHEEP; ULTRASONOGRAPHY, PRENATAL; UMBILICAL VEINS;

ADENOVIRIDAE; ANIMALIA; OVIS ARIES;

EID: 0037338159     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321208952     Document Type: Article

References (36)

1. BAMBACH, B.J., MOSER, H.W., BLAKEMORE, K., CORSON, V.L., GRIFFIN, C.A., NOGA, S.J., PERLMAN, E.J., ZUCKERMAN, R., WENGER, D.A., and JONES, R.J. (1997). Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant 19, 399-402.
2. BARBERA, A., JONES, O.W., ZERBE, G.W., HOBBINS, J.C., BATTAGLIA, F.C., and MESCHIA, G. (1995). Ultrasonographic assessment of fetal growth: Comparison between human and ovine fetus. Am. J. Obstet. Gynecol. 173, 1765-1769.
3. BILLINGHAM, R.E., BRENT, L., and MEDAWAR, P.B. (1956). Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos. Trans. R. Soc. Lond. B239, 357-369.
4. BILLINGS, P.R. (1999). In utero gene therapy: The case against. Nat. Med. 5, 255-256.
5. BINNS, R. (1967). Bone marrow and lymphoid cell injection of the pig fetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature 214, 179-180.
6. CHARTIER, C., DEGRYSE, E., GANTZER, M., DIETERLE, A., PAVIRANI, A., and MEHTALI, M. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70, 4805-4810.
7. CHU, T.T., and DORNBURG, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69, 2659-2663
8. CLOETE, J.H.L. (1939). Prenatal growth in the merino sheep. Onderstepoort J. Vet. Sci. 13, 417-557.
9. COOKE, I.R., and BERGER, P.J. (1990). Precursor of respiratory pattern in the early gestation mammalian fetus. Brain Res. 522, 333-336.
10. COUZIN, J. (1998). RAC confronts in utero gene therapy proposals. Science 282, 27.
11. DOUAR, A-M., ADEBAKIN, S., THEMIS, M., PAVIRANI, A., COOK, T., and COUTELLE, C. (1997). Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther. 4, 883-890.
12. FAHEY, K.J., and MORRIS, B. (1978). Humoral immune responses in foetal sheep. Immunology 35, 651-661.
13. FLAKE, A.W., RONCAROLO, M.G., PUCK, J.M., ALMEIDA-PORADA, G., EVANS, M.I., JOHNSON, M.P., ABELLA, E.M., HARRISON, D.D., and ZANJANI, E.D. (1996). Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N. Engl. J. Med. 335, 1806-1810.
14. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-457.
15. HATZOGLOU, M., MOORMAN, A., and LAMERS, W. (1995). Persistent expression of genes transferred in the fetal rat liver via retroviruses. Somat. Cell Mol. Genet. 21, 265-278.
16. HERZOG, R.W., YANG, E.Y., COUTO, L.B., HAGSTROM, J.N., ELWELL, D., FIELDS, P.A., BURTON, M., BELLINGER, D.A., READ, M.S., BRINKHOUS, D.M., PODSAKOFF, G.M., NICHOLS, T.C., KURTZMAN, G.J., and HIGH, K.A. (1999). Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56-63.
17. KELLY, R.W., and NEWNHAM, J.P. (1989). Estimation of gestational age in Merino ewes by ultrasound measurement of fetal head size. Aust. J. Agric. Res. 40, 1293-1299.
18. LIPSHUTZ, G.S., FLEBBE-REHWALDT, L., and GAENSLER, K.M.L. (1999a). Adenovirus-mediated gene transfer in the midgestation fetal mouse. J. Surg. Res. 84, 150-156.
19. LIPSHUTZ, G.S., FLEBBE-REHWALDT, L., and GAENSLER, K.M.L. (1999b). Adenovirus-mediated gene transfer to the peritoneum and hepatic parenchyma of fetal mice in utero. Surgery 126, 171-177.
20. LIPSHUTZ, G.S., FLEBBE-REHWALDT, L., and GAENSLER, K.M.L. (2000). Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol. Ther. 2, 374-380.
21. LÖSER, P., JENNINGS, G.S., STRAUSS, M., and SANDIG, V. (1998). Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkB. J. Virol. 72, 180-190.
22. MORRIS, B. (1986). The ontogeny and comportment of lymphoid cells in fetal and neonatal sheep. Immunol. Rev. 91, 219-233.
23. NYBERG-HOFFMAN, C., SHABRAM, P., LI, W., GIROUX, D., and AGUILAR-CORDOVA, E. (1997). Sensitivity and reproducibility in adenoviral infectious titer determination. Nat. Med. 3, 808-811.
24. ORLANDI, F., DAMIANI, G., JAKIL, C., LAURICELLA, S., BERTOLINO, O., and MAGGIO, A. (1990). The risks of early cordocentesis (12-21 weeks): Analysis of 500 procedures. Prenat. Diagn. 10, 425-428.
25. r gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum. Gene. Ther. 9, 1571-1585.
26. RILEY, R.L. (1998). Neonatal immune response. In Encyclopedia of Immunology. P.J. Delves and I.M. Roitt eds. (Academic Press, London, UK) pp. 1818-1821.
27. RODECK, C.H., DEANS, A. (1999). Red cell alloimmunisation. In Fetal Medicine: Basic Science and Clinical Practice. C.H. Rodeck and M.J. Whittle eds. (Churchill Livingstone, London, UK) pp. 785-804.
28. SADLER, T.W. (1990). Langman's Medical Embryology. (Williams & Wilkins, Baltimore, MD) pp. 248-250.
29. SCHNEIDER, H., ADEBAKIN, S., THEMIS, M., COOK, T., DOUAR, A-M., PAVIRANI, A., and COUTELLE, C. (1999). Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. J. Gene Med. 1, 424-432.
30. SCHNEIDER, H., MÜHLE, C., DOUAR, A-M., WADDINGTON, S., JIANG, Q-J., VON DER MARK, K., COUTELLE, C., and RASCHER, W. (2002). Sustained delivery of therapeutic concentrations of human clotting factor IX: A comparison of adenoviral and AAV vectors administered in utero. J. Gene Med. 4, 46-53.
31. SILVERSTEIN, A.M., UHR, J.W., and LUKES, R.J. (1963). Fetal response to antigenic stimulus II. Antibody production by the fetal lamb. J. Exp. Med. 117, 799-812.
32. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
33. THEMIS, M., SCHNEIDER, H., KISERUD, T., COOK, T., ADEBAKIN, S., JEZZARD, S., FORBES, S., HANSON, M., PAVIRANI, A., RODECK, C., and COUTELLE, C. (1999). Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Ther. 6, 1239-1248.
34. TRAN, N.D., PORADA, C.D., ALMEIDA-PORADA, G., GLIMP, H.A., ANDERSON, W.F., and ZANJANI, E.D. (2001). Induction of stable prenatal tolerance to β-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood 97, 3417-3423.
35. TRAN, N.D., PORADA, C.D., ZHAO, Y., ALMEIDA-PORADA, G., ANDERSON, W.F., and ZANJANI, E.D. (2000). In utero transfer and expression of exogenous genes in sheep. Exp. Hematol. 28, 17-30.
36. WADDINGTON, S.N., BUCKLEY, S.M., NIVSARKAR, M., JEZZARD, S., SCHNEIDER, H., DAHSE, T., KEMBALL-COOK, G., MIAH, M., TUCKER, N., DALLMAN, M.J., THEMIS, M., and COUTELLE, C. (2002) In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor. Blood. 2002 Oct 3 [epub ahead of print].